tiprankstipranks
Lipocine (DE:2VT)
FRANKFURT:2VT

Lipocine (2VT) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Lipocine’s (2VT) Moving Averages Convergence Divergence (MACD) indicator is -0.23, suggesting Lipocine is a Sell.
Lipocine’s (2VT) 20-Day exponential moving average is 3.76, while Lipocine’s (2VT) share price is €3.672, making it a Sell.
Lipocine’s (2VT) 50-Day exponential moving average is 4.46, while Lipocine’s (2VT) share price is €3.672, making it a Sell.

Lipocine (2VT) Pivot Points

Apr 28, 2024, 02:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.45
2.56
3.12
4.23
4.78
5.89
6.45
Fibonacci
2.56
3.20
3.59
4.23
4.86
5.26
5.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lipocine (2VT) Moving Averages

Apr 28, 2024, 02:20 AM
Period
Simple
Exponential
MA5
3.67Sell
3.66Buy
MA10
3.56Buy
3.64Buy
MA20
3.69Sell
3.76Sell
MA50
4.33Sell
4.46Sell
MA100
5.91Sell
5.46Sell
MA200
6.86Sell
7.18Sell
Lipocine’s (2VT) 10-Day exponential moving average is 3.64, while Lipocine’s (2VT) share price is €3.672, making it a Buy.
Lipocine’s (2VT) 100-Day exponential moving average is 5.46, while Lipocine’s (2VT) share price is €3.672, making it a Sell.
Lipocine’s (2VT) stock price is €3.672 and Lipocine’s (2VT) 50-day simple moving average is 4.33, creating a Sell signal.
Lipocine’s (2VT) stock price is €3.672 and Lipocine’s (2VT) 100-day simple moving average is 5.91, creating a Sell signal.
Lipocine’s (2VT) stock price is €3.672 and Lipocine’s (2VT) 200-day simple moving average is 6.86, creating a Sell signal.

Lipocine (2VT) Technical Indicators

Apr 28, 2024, 02:20 AM
Name
Value
Implied Action
RSI (14)
40.51
Neutral
STOCH (9,6)
20.11
Neutral
STOCHRSI (14)
20.33
Neutral
MACD (12,26)
-0.23
Sell
ADX (14)
33.76
Neutral
Williams %R
-79.67
Buy
CCI (14)
93.83
Neutral
ATR (14)
0.52
-
Ultimate Oscillator
5.26
Sell
ROC
-6.09
Sell
Lipocine’s (2VT) Relative Strength Index (RSI) is 40.51, creating a Neutral signal.
Lipocine’s (2VT) Trend Strength Indicator (ADX) is 33.76, creating a Neutral signal.
Lipocine’s (2VT) Commodity Channel Index (CCI) is 93.83, creating a Neutral signal.
Lipocine’s (2VT) Price Rate of Change (ROC) is -6.09, creating a Sell signal.

FAQ

Is 2VT a Buy, Hold, or Sell?
Based on 2VT’s technical indicators, 2VT is a Sell.
    What is 2VT’s RSI (14)?
    2VT’s RSI (14) is 40.51, which suggests 2VT is a Neutral.
      What is 2VT’s MACD?
      2VT’s MACD is -0.23, which suggests 2VT is a Sell.
        What is 2VT’s 5-day moving average?
        2VT’s 5-day moving average is 3.67, which suggests 2VT is a Sell.
          What is 2VT’s 20-day moving average?
          2VT 20-day moving average is 3.69, which suggests 2VT is a Sell.
            What is 2VT’s 50-day moving average?
            2VT’s 50-day moving average is 4.33, which suggests 2VT is a Sell.
              What is 2VT’s 200-day moving average?
              2VT’s 200-day moving average is 6.86, which suggests 2VT is a Sell.
                What is 2VT’s Williams % R (14)?
                2VT’s Williams % R (14) is -79.67, which suggests 2VT is a Buy.
                  What is 2VT’s CCI (14)?
                  2VT’s CCI (14) is 93.83, which suggests 2VT is a Neutral.
                    What is the share price of Lipocine?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis